Exarafenib
| CAS No. | 2639957-39-2 | Cat. No. | BCP49200 |
| Name | Exarafenib | ||
| Synonyms | RAF/KIN_2787; KIN-2787; KIN 2787; KIN2787; | ||
| Formula | C26H34F3N5O3 | M. Wt | 521.58 |
| Description | Exarafenib is an orally available inhibitor of class I, II, and III B-Raf (BRAF) protein kinases, with potential antineoplastic activity. Upon administration, exarafenib binds to and inhibits Class I, Class II, or Class III B-Raf mutations. This prevents B-Raf-mediated signal transduction pathways, which may lead to an inhibition of tumor growth in B-Raf mutant cells. B-Raf protein kinases play a key role in the RAF/MEK/ERK signaling pathway, which is often deregulated and mutated in human cancers, and plays a key role in tumor cell proliferation and survival. | ||
| Pathways | MAPK Pathway | ||
| Targets | p38 MAPK Raf | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.